US Stock MarketDetailed Quotes

ARS Pharmaceuticals (SPRY)

Watchlist
  • 7.425
  • -0.515-6.49%
Close May 15 16:00 ET
  • 7.800
  • +0.375+5.05%
Post 19:31 ET
737.33MMarket Cap-3.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals (SPRY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-5.46%84.28M
-67.56%28.09M
1,471.62%32.5M
3,043.40%15.72M
7.97M
297,063.33%89.15M
86.58M
2.07M
4,900.00%500K
0
Operating revenue
-5.46%84.28M
-67.56%28.09M
1,471.62%32.5M
3,043.40%15.72M
--7.97M
297,063.33%89.15M
--86.58M
--2.07M
4,900.00%500K
--0
Cost of revenue
1,990.38%20.42M
611.45%6.15M
7,213.39%8.19M
4.98M
1.09M
977K
865K
112K
0
0
Gross profit
-27.58%63.86M
-74.41%21.93M
1,142.84%24.31M
2,046.60%10.73M
6.88M
293,806.67%88.17M
85.72M
1.96M
500K
0
Operating expense
166.62%243.3M
64.59%63.4M
226.96%77.5M
268.35%58.35M
233.96%44.06M
35.09%91.26M
276.68%38.52M
31.85%23.7M
-23.16%15.84M
-29.58%13.19M
Selling and administrative expenses
221.06%230.12M
68.93%59.96M
287.69%74.75M
507.25%54.31M
416.51%41.1M
51.58%71.68M
420.26%35.49M
28.75%19.28M
-32.78%8.94M
-34.67%7.96M
Research and development costs
-32.68%13.18M
13.74%3.44M
-37.80%2.75M
-41.49%4.04M
-43.60%2.95M
-3.38%19.58M
-11.08%3.03M
47.34%4.42M
-5.64%6.9M
-20.12%5.23M
Operating profit
-5,720.56%-179.45M
-187.86%-41.47M
-144.58%-53.19M
-210.39%-47.61M
-181.81%-37.18M
95.43%-3.08M
561.54%47.2M
-20.97%-21.75M
25.54%-15.34M
29.50%-13.19M
Net non-operating interest income expense
-29.02%8.07M
11.37M
Non-operating interest income
-6.16%10.67M
----
----
----
----
--11.37M
----
----
----
----
Non-operating interest expense
--2.6M
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-22.10%2.04M
-3.29%2.73M
11.62%3.24M
-13.58%11.37M
-1.08%3.03M
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
Other non- operating income (expenses)
----
----
-22.10%2.04M
-3.29%2.73M
11.62%3.24M
-13.58%11.37M
-1.08%3.03M
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
Income before tax
-2,168.28%-171.38M
-182.44%-41.4M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
115.24%8.29M
800.64%50.22M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Income tax
-127.78%-80K
288K
Net income
-2,241.76%-171.3M
-182.76%-41.32M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Net income continuous Operations
-2,241.76%-171.3M
-182.76%-41.32M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Minority interest income
Net income attributable to the parent company
-2,241.76%-171.3M
-182.76%-41.32M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2,241.76%-171.3M
-182.76%-41.32M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Basic earnings per share
-2,275.00%-1.74
-182.35%-0.42
-160.00%-0.52
-253.85%-0.46
-218.18%-0.35
114.04%0.08
828.57%0.51
-25.00%-0.2
27.78%-0.13
31.25%-0.11
Diluted earnings per share
-2,275.00%-1.74
-182.35%-0.42
-160.00%-0.52
-253.85%-0.46
-218.18%-0.35
114.04%0.08
828.57%0.51
-25.00%-0.2
27.78%-0.13
31.25%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -5.46%84.28M-67.56%28.09M1,471.62%32.5M3,043.40%15.72M7.97M297,063.33%89.15M86.58M2.07M4,900.00%500K0
Operating revenue -5.46%84.28M-67.56%28.09M1,471.62%32.5M3,043.40%15.72M--7.97M297,063.33%89.15M--86.58M--2.07M4,900.00%500K--0
Cost of revenue 1,990.38%20.42M611.45%6.15M7,213.39%8.19M4.98M1.09M977K865K112K00
Gross profit -27.58%63.86M-74.41%21.93M1,142.84%24.31M2,046.60%10.73M6.88M293,806.67%88.17M85.72M1.96M500K0
Operating expense 166.62%243.3M64.59%63.4M226.96%77.5M268.35%58.35M233.96%44.06M35.09%91.26M276.68%38.52M31.85%23.7M-23.16%15.84M-29.58%13.19M
Selling and administrative expenses 221.06%230.12M68.93%59.96M287.69%74.75M507.25%54.31M416.51%41.1M51.58%71.68M420.26%35.49M28.75%19.28M-32.78%8.94M-34.67%7.96M
Research and development costs -32.68%13.18M13.74%3.44M-37.80%2.75M-41.49%4.04M-43.60%2.95M-3.38%19.58M-11.08%3.03M47.34%4.42M-5.64%6.9M-20.12%5.23M
Operating profit -5,720.56%-179.45M-187.86%-41.47M-144.58%-53.19M-210.39%-47.61M-181.81%-37.18M95.43%-3.08M561.54%47.2M-20.97%-21.75M25.54%-15.34M29.50%-13.19M
Net non-operating interest income expense -29.02%8.07M11.37M
Non-operating interest income -6.16%10.67M------------------11.37M----------------
Non-operating interest expense --2.6M------------------0----------------
Other net income (expense) -22.10%2.04M-3.29%2.73M11.62%3.24M-13.58%11.37M-1.08%3.03M-15.81%2.62M-12.65%2.82M-22.71%2.9M
Other non- operating income (expenses) ---------22.10%2.04M-3.29%2.73M11.62%3.24M-13.58%11.37M-1.08%3.03M-15.81%2.62M-12.65%2.82M-22.71%2.9M
Income before tax -2,168.28%-171.38M-182.44%-41.4M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M115.24%8.29M800.64%50.22M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Income tax -127.78%-80K288K
Net income -2,241.76%-171.3M-182.76%-41.32M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Net income continuous Operations -2,241.76%-171.3M-182.76%-41.32M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Minority interest income
Net income attributable to the parent company -2,241.76%-171.3M-182.76%-41.32M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2,241.76%-171.3M-182.76%-41.32M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Basic earnings per share -2,275.00%-1.74-182.35%-0.42-160.00%-0.52-253.85%-0.46-218.18%-0.35114.04%0.08828.57%0.51-25.00%-0.227.78%-0.1331.25%-0.11
Diluted earnings per share -2,275.00%-1.74-182.35%-0.42-160.00%-0.52-253.85%-0.46-218.18%-0.35114.04%0.08828.57%0.51-25.00%-0.227.78%-0.1331.25%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -